Abstract:Methuosis is a newly defined nonapoptotic cell death characterized by the accumulation of large liquid-filled vacuoles in cytoplasm, which is distinct from necrosis, autophagy and apoptosis. A novel azaindole-based methuosis inducer, named HZX-02-059, displays cytotoxic effects to a series of cancer cellular models via blocking the role of PIKfyve. The discovery of HZX-02-059 sheds light on a novel therapeutic option for refractory cancer patients who have limited effective treatments. Despite significant advances in treatments, over 50% of adult patients with B-cell acute lymphoblastic leukemia (B-ALL) fail to achieve durable responses with current intensive chemotherapies, which highlight an urgent need of new therapeutic regimens for this patient population. Here, we applied HZX-02-059 to B-ALL cell lines and mice models to uncover its potential role and underlying mechanism. Morphology changes of HZX-02-059-treated B-ALL cells were observed under the light microscope, and these treated cells were to certain extent collapsed into debris. Of note, higher concentration of this compound induced the accumulation of substantial larger vacuoles in cytoplasm. To assess the cytotoxicity of this compound, we performed cell counting kit-8 (CCK-8) and colony forming unit (CFU) assays. As expected, HZX-02-059 significantly inhibited cancer cell proliferation and reduced the capability of cell colony forming in a dose-dependent manner. Next, we carried out an EdU assay to determine the influence of HZX-02-059 on cell cycle distribution. As a result, B-ALL cells treated with HZX-02-059 were mainly blocked at G2/M phase. Western blotting was conducted to investigate the underlying molecular basis of HZX-02-059 in B-ALL. To the end, we found that HZX-02-059 negatively regulated the proteins involved in the PI3K/AKT pathway. Also, this drug decreased the expression of the pathway downstream transcription factors NF-ǐB and c-Myc, suggesting that the dysregulation of the PI3K/AKT axis is a potential mechanism of action of HZX-02-059 against B-ALL. To further evaluate itsin vivotherapeutic effect, B-ALL patient-derived xenograft (PDX) mice were established and administrated with HZX-02-059. The result revealed a survival benefit of the treatment as compared with the control, which grants this molecule great potential for clinical usage. Thus, our results suggest that HZX-02-059 is a potent anti-BALL reagent in preclinical models that warrant further investigation of this drug as an alternative therapeutic strategy for B-ALL patients who are resistant to conventional therapies. Disclosures No relevant conflicts of interest to declare.

4-(4-Bromopheny1)-2,3-dihydro-n,3-bis(3,4,5-trimethoxyphenyl)-2-oxoidmid Azole-1-Carboxamide Induces Apoptosis in Human Leukemia Cells Through Mitochondrial Pathway

Mz3 Can Induce G2/M-Phase Arrest and Apoptosis in Human Leukemia Cells

MZ3 Induces Apoptosis in Human Leukemia Cells

MZ3 can disturb tubulin polymerization and cause G2/M cell cycle arrest in human leukemia cells

Effect of 5-Aza-2′-deoxycytidine in High-Risk Myelodysplasia Cells in Vitro.

Antimultidrug-Resistant Effect and Mechanism of A Novel Ca-4 Analogue Mz3 on Leukemia Cells

The Novel Synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) Compound Induces G(2)/M Phase Arrest and Mitochondrial-Dependent Apoptotic Cell Death Through Inhibition of Cdk1 and Akt Activity in Hl-60 Human Leukemia Cells

4-Chlorobenzoyl Berbamine, a Novel Berbamine Derivative, Induces Apoptosis in Multiple Myeloma Cells Through the IL-6 Signal Transduction Pathway and Increases FOXO3a-Bim Expression.

A Novel Bcl-2 Small Molecule Inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (Mnb)-Induced Apoptosis in Leukemia Cells

Berbamine Selectively Induces Apoptosis of Human Acute Promyelocytic Leukemia Cells Via Survivin-Mediated Pathway

4-Methylthiazole triggers apoptosis and mitochondrial disruption in HL-60 cells

Studies on the Effects of Berbamine on the Human Leukemia Cell Line Nb4.

SMT-A07, a 3-(Indol-2-yl) indazole derivative, induces apoptosis of leukemia cells in vitro

Increased 14-3-3 Zeta Expression In The Multidrug-Resistant Leukemia Cell Line Hl-60/Vcr As Compared To The Parental Line Mediates Cell Growth And Apoptosis In Part Through Modification Of Gene Expression

Apoptosis Induced by DNA Primase Inhibitor 3,3'-Diethyl-9-methylthia-carbocyanine Iodide in Human Leukemia HL-60 Cells.

3,6-Dihydroxyflavone Induces Apoptosis in Leukemia HL-60 Cell Via Reactive Oxygen Species-Mediated P38 MAPK/JNK Pathway

Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells

A novel organic arsenic derivative MZ2 remodels metabolism and triggers mtROS-mediated apoptosis in acute myeloid leukemia

III-10, a Newly Synthesized Flavonoid, Induces Cell Apoptosis with the Involvement of Reactive Oxygen Species-Mitochondria Pathway in Human Hepatocellular Carcinoma Cells.

APG-1252-12A Induces Mitochondria-Dependent Apoptosis Through Inhibiting the Antiapoptotic Proteins Bcl-2/Bcl-xl in HL-60 Cells

An Azaindole-Based Small Molecule Hzx-02-059 Induces Methuosis in B-Cell Acute Lymphoblastic Leukemia Through the PI3K/AKT Axis